No black box warning on record for Icotyde

As of the latest FDA labeling reviewed, Icotyde (ICOTROKINRA) does not carry a black box warning. Standard warnings and precautions still apply — see the full Icotyde medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Infections : Avoid treatment with ICOTYDE in patients with any clinically important active infection until the infection resolves or is adequately treated. If such an infection develops, discontinue ICOTYDE until the infection resolves. ( 5.1 ) Tuberculosis (TB) : Consider evaluating for TB prior to initiating treatment with ICOTYDE based on clinical judgment. Monitor pa

No black box warning on record for Icotyde

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Infections : Avoid treatment with ICOTYDE in patients with any clinically important active infection until the infection resolves or is adequately treated. If such an infection develops, discontinue ICOTYDE until the infection resolves. ( 5.1 ) Tuberculosis (TB) : Consider evaluating for TB prior to initiating treatment with ICOTYDE based on clinical judgment. Monitor pa

Icotyde Black Box Warning

No black box warning on record for Icotyde

Other warnings & precautions

Icotyde Black Box Warning

No black box warning on record for Icotyde

Other warnings & precautions